Share your research ideas with our experts: Euro Heart Failure 2023
Heart failure is a chronic, progressive condition in which the heart muscle is unable to pump enough blood to meet the body’s needs for blood and oxygen. Basically, the heart can’t keep up with its workload. Heart failure is caused due to failure of heart to pump an in-adequate supply of oxygen rich blood which causes disruption in functioning of body. Heart failure is a condition of collection of symptoms which weakens your heart
Symptoms of Heart Failure:
- Excessive Fatigue
- Abdominal Swelling
- shortness of breath
- heart palpitations
- a loss of appetite
- sudden weight gain
EURO HEART FAILURE 2023 Committee we invite all the eminent speakers round the world to attend the EURO HEART FAILURE 2023 conference scheduled on April 13-14, 2023 at Paris, France
EURO HEART FAILURE 2023 The incorporation of new technologies and research findings will be a special focus of the Congress. It will also bring together expert clinicians, researchers and leaders of cardiac health stakeholder organisations, offering an outstanding set of plenary and state-of - the-art lectures, educational courses, Online symposia with experts and sessions designed by cardiology professionals and cardiac specialists and for early careers.
EURO HEART FAILURE 2023 is an international conference of cardiologists and heart failure committee to discuss the future of cardiac health and cardiovascular disorders in terms of collaboration, structures and organizational development and advances in cardio-metabolic health and Interventional Cardiology.
The participants can find exclusive sessions and panel discussions on latest revolutions in Cardiac Surgeries and Heart Failure by:
- Lectures from renowned speakers
- Keynote forums by Prominent Professors
- Open Invention Challenges
- Live video presentations by Young Researchers
- Unique techniques to improve your research
- Perfect platform for World-wide business and Networking opportunities
- Come across with the editors of referred journals, Society and Association members across the world
Highlighted Sessions:
Neuro-cardiologyCardio-oncology
Artificial Intelligence in Cardiology
Market Analysis - Euro Heart Failure 2023: Heart failure affects people of all ages, from children and young adults to the middle-aged and the senior citizens. Almost 1.4 million persons with CHD are under 60 years of age. CHD is present in 2 percent of persons age 40 to 59. More than 5 percent of persons age 60 to 69 have CHD. According to the latest WHO data published in 2017 Coronary Heart Disease Demises in France reached 33,637 or 35.02% of total deaths. Survival rates in patients with heart failure were 75.9% (95% confidence interval 75.5% to 76.3%) at one year, 45.5% (45.1 to 46.0) at five years, 24.5% (23.9 to 25.0) at 10 years, and 12.7% (11.9 to 13.5) at 15 years. Since 2006 to 2016, the yearly mortality rate creditable to coronary heart disease declined 31.8% and the actual number of deaths declined 14.6%, but the problem and risk factors remain terrifyingly high. The estimated direct and indirect cost of heart disease in 2015 to 2016 (average annual) was $218.7 billion.
Growth of Cardiology Market:- Overall, one, five, and 10 year survival rates increased by 6.6% (from 74.2% in 2000 to 80.8% in 2016), 7.2% (from 41.0% in 2000 to 48.2% in 2012), and 6.4% (from 19.8% in 2000 to 26.2% in 2007), respectively. There were 30 906 demises in the heart failure group over the study period. Heart failure was listed on the death record in 13 093 (42.4%) of these patients, and in 2237 (7.2%) it was the primary cause of death. Improvement in survival was greater for patients not requiring admission to hospital around the time of diagnosis (median difference 2.4 years; 5.3 v 2.9 years, P<0.001). There was a deprivation gap in median survival of 0.5 years between people who were least deprived and those who were most deprived (4.6 v 4.1 years, P<0.001).
The goal of this is to evaluate cardiovascular risk among the France population quantify the impact of main risk factors on cardiovascular mortality and to identify potential modifiable factors for improving the cardiovascular health
Visit for more information and join us: https://heartdiseases.conferenceseries.com/